Authors:
Buckley, C
Douek, D
Newsom-Davis, J
Vincent, A
Willcox, N
Citation: C. Buckley et al., Mature, long-lived CD4(+) and CD8(+) T cells are generated by the thymoma in myasthenia gravis, ANN NEUROL, 50(1), 2001, pp. 64-72
Authors:
Curnow, J
Corlett, L
Willcox, N
Vincent, A
Citation: J. Curnow et al., Presentation by myoblasts of an epitope from endogenous acetylcholine receptor indicates a potential role in the spreading of the immune response, J NEUROIMM, 115(1-2), 2001, pp. 127-134
Citation: I. Roxanis et al., True epithelial hyperplasia in the thymus of early-onset myasthenia gravispatients: implications for immunopathogenesis, J NEUROIMM, 112(1-2), 2001, pp. 163-173
Authors:
Buckley, C
Newsom-Davis, J
Willcox, N
Vincent, A
Citation: C. Buckley et al., Do titin and cytokine antibodies in MG patients predict thymoma or thymomarecurrence?, NEUROLOGY, 57(9), 2001, pp. 1579-1582
Citation: Gp. Sims et al., Somatic hypermutation and selection of B cells in thymic germinal centers responding to acetylcholine receptor in myasthenia gravis, J IMMUNOL, 167(4), 2001, pp. 1935-1944
Authors:
Matsuo, H
Corlett, L
Hawke, S
Nicolle, M
Driscoll, P
Deshpande, S
Spack, E
Willcox, N
Citation: H. Matsuo et al., Distant interactions between dimorphisms in HLA-DR4 radically affect recognition of defined peptides by a specific T cell clone, INT IMMUNOL, 11(5), 1999, pp. 835-843
Authors:
Hill, M
Beeson, D
Moss, P
Jacobson, L
Bond, A
Corlett, L
Newsom-Davis, J
Vincent, A
Willcox, N
Citation: M. Hill et al., Early-onset myasthenia gravis: A recurring T-cell epitope in the adult-specific acetylcholine receptor epsilon subunit presented by the susceptibility allele HLA-DR52a, ANN NEUROL, 45(2), 1999, pp. 224-231
Citation: A. Vincent et N. Willcox, The role of T-cells in the initiation of autoantibody responses in thymomapatients, PATH RES PR, 195(8), 1999, pp. 535-540
Authors:
Janer, M
Cowland, A
Picard, J
Campbell, D
Pontarotti, P
Newsom-Davis, J
Bunce, M
Welsh, K
Demaine, A
Wilson, AG
Willcox, N
Citation: M. Janer et al., A susceptibility region for myasthenia gravis extending into the HLA-classI sector telomeric to HLA-C, HUMAN IMMUN, 60(9), 1999, pp. 909-917
Authors:
Hill, M
Moss, P
Wordsworth, P
Newsom-Davis, J
Willcox, N
Citation: M. Hill et al., T cell responses to D-penicillamine in drug-induced myasthenia gravis: recognition of modified DR1 : peptide complexes, J NEUROIMM, 97(1-2), 1999, pp. 146-153
Authors:
Nagvekar, N
Corlett, L
Jacobson, LW
Matsuo, H
Chalkley, R
Driscoll, PC
Deshpande, S
Spack, EG
Willcox, N
Citation: N. Nagvekar et al., Scanning a DRB30101 (DR52a)-restricted epitope cross-presented by DR3: Overlapping natural and artificial determinants in the human acetylcholine receptor, J IMMUNOL, 162(7), 1999, pp. 4079-4087
Authors:
Meager, A
Wadhwa, M
Bird, C
Dilger, P
Thorpe, R
Newsom-Davis, J
Willcox, N
Citation: A. Meager et al., Spontaneously occurring neutralizing antibodies against granulocyte-macrophage colony-stimulating factor in patients with autoimmune disease, IMMUNOLOGY, 97(3), 1999, pp. 526-532
Authors:
Hawke, S
Matsuo, H
Nicolle, M
Wordsworth, P
Corlett, L
Spack, E
Deshpande, S
Driscoll, PC
Willcox, N
Citation: S. Hawke et al., Cross-restriction of a T cell clone to HLA-DR alleles associated with rheumatoid arthritis - Clues to arthritogenic peptide motifs, ARTH RHEUM, 42(5), 1999, pp. 1040-1050